Inbiotec Amber and Mesosinia in Hong Kong
In an effort to expand its presence and present its innovations in aesthetic medicine in the Asian market, IT Pharma held a series of activities in Hong Kong from July 29-31.
In an effort to expand its presence and present its innovations in aesthetic medicine in the Asian market, IT Pharma held a series of activities in Hong Kong from July 29-31.
IT Pharma expands its presence in Asia by introducing Inbiotec Amber, its succinic acid and hyaluronic acid injectable, to the Asian market during an intense week of medical training and collaborations with the country’s scientific community.
A versatile cream, dermatologically tested on reactive skin. Perfect for protecting the skin after aesthetic treatments and as a daily sunscreen to shield against all types of radiation, while soothing and caring for your skin.
The participation in this event of Skyview, IT Pharma’s distributor in China, underlines the company’s commitment to expanding and consolidating its presence in the Asian market.
A group of twelve professionals from the Latin American healthcare sector, specialists in general and family medicine, surgery, internal medicine, biochemistry and nursing, visited IT Pharma with Foro Europeo, Navarra Business School.
In recent years, interest in the natural harmonisation of the face has increased considerably, and this is reflected in treatments such as those of…
From 23 May to 25 May, the XVII edition of the Aesthetic Medicine Congress was held in Caracas…
XVII edition of the Congress of Aesthetic Medicine in Caracas…
On 15 May 2024, the first launch of IT Pharma in China took place in Guangzhou, one of the top 100 cities in the cosmetic and aesthetic medicine industry.
After an aesthetic or cosmetic medicine treatment, it is very likely that you may suffer some kind of skin irritation, have more exposed dermis…
The concern of having damaged hair and its consequent loss due to the fear of not regenerating again in the follicles is becoming more and
© 2020 ItPharma